VWR Acquires High-Purity Reagents Firm
By

By
VWR has acquired Seastar Chemicals, a manufacturer of highpurity reagents headquartered in Sydney, British Columbia, Canada. Seastar’s high-purity reagents are used in the research, laboratory, and microelectronics industries. The company…

Cerbios’ HPAI Plant Passes Swiss Inspection
By

By
Cerbios-Pharma, a Lugano, Switzerland-headquartered contract development and manufacturing organization, has passed a SwissMedic cGMP inspection for its new super critical carbon dioxde atomization plant. The plant is now authorized for both…

IDT Biologika Launches Animal Health Business
By

By
IDT Biologika, a Dessau, Germany-headquartered biopharmaceutical company, has established a new animal health organization in the Americas, IDT Animal Health Americas, which will offer a range of autogenous, wildlife, and…

Sartorius Stedim Opens Bioanalytical Lab in China
By

By
Sartorius Stedim Biotech (SSB), a supplier for the biopharmaceutical industry, has opened a new bioanalytical and biosafety testing laboratory in Boston, Massachusetts designed for the company’s BioOutsource brand assay platforms.…

Horizon Extends CRISPR License for Cell-Line Manufacture
By

By
Horizon Discovery Group, a gene-editing company headquartered in Waterbeach, UK, has amended a pre-existing license with ERS Genomics, based in Dublin, Ireland, to include the full commercial rights for the…

MilliporeSigma Opens Excipients Manufacturing Plant
By

By
MilliporeSigma has opened a manufacturing facility in Mollet des Vallès, Spain to manufacture meglumine, a US Food and Drug Administration (FDA)-approved excipient for pharmaceuticals and a component of medical imaging…

Dalton in Formulation, Manufacturing Deal
By

By
Dalton Pharma Services, a contract service provider of chemistry, drug development, and manufacturing services, based in North York, Ontario, Canada, has signed a drug development and manufacturing services agreement with…

Eisai Acquires Manufacturing Rights to Insomnia Drug API
By

By
Eisai, Chugai Pharmaceutical, and Roche have agreed that Eisai will acquire the manufacturing rights in Japan for the active pharmaceutical ingredient (API) for the insomnia treatment and anesthesia induction agent,…

Astellas Terminates Vaccines Pact
By

By
Astellas Pharma has terminated an agreement that was executed in September 2010 between it and UMN Pharma, a pharmaceutical company headquartered in Kanagawa, Japan for the co-development and Astellas’ exclusive…

Takeda Partners in ADCs
By

By
Takeda Pharmaceutical has entered into a research licensing agreement with LegoChem Biosciences (LCB), a biopharmaceutical company based in Daejeon, South Korea to evaluate next-generation antibody drug conjugate (ADC) candidates. Under…